- Home
- GES vs PLSE Comparison
GES vs PLSE Comparison
Compare GES & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GES
- PLSE
- Stock Information
- Founded
- GES 1981
- PLSE 2014
- Country
- GES Switzerland
- PLSE United States
- Employees
- GES N/A
- PLSE N/A
- Industry
- GES Apparel
- PLSE Medical/Dental Instruments
- Sector
- GES Consumer Discretionary
- PLSE Health Care
- Exchange
- GES Nasdaq
- PLSE Nasdaq
- Market Cap
- GES 547.7M
- PLSE 1.1B
- IPO Year
- GES 1996
- PLSE 2016
- Fundamental
- Price
- GES $12.46
- PLSE $14.84
- Analyst Decision
- GES Buy
- PLSE
- Analyst Count
- GES 4
- PLSE 0
- Target Price
- GES $17.75
- PLSE N/A
- AVG Volume (30 Days)
- GES 900.8K
- PLSE 190.1K
- Earning Date
- GES 06-05-2025
- PLSE 08-11-2025
- Dividend Yield
- GES 9.61%
- PLSE N/A
- EPS Growth
- GES N/A
- PLSE N/A
- EPS
- GES 0.10
- PLSE N/A
- Revenue
- GES $3,051,131,000.00
- PLSE N/A
- Revenue This Year
- GES $7.34
- PLSE N/A
- Revenue Next Year
- GES $3.20
- PLSE N/A
- P/E Ratio
- GES $129.19
- PLSE N/A
- Revenue Growth
- GES 9.02
- PLSE N/A
- 52 Week Low
- GES $8.48
- PLSE $10.52
- 52 Week High
- GES $24.64
- PLSE $25.00
- Technical
- Relative Strength Index (RSI)
- GES 57.92
- PLSE 35.78
- Support Level
- GES $11.80
- PLSE $14.76
- Resistance Level
- GES $12.16
- PLSE $15.40
- Average True Range (ATR)
- GES 0.42
- PLSE 0.70
- MACD
- GES 0.02
- PLSE -0.08
- Stochastic Oscillator
- GES 71.53
- PLSE 8.33
About GES Guess? Inc.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.